Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-13 · accession 0001334549-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-18 | 2022-01-13+ | LSTA | Mazzo David J | CEO, Dir | F - Tax | $0.8151 | -13.1K | 631.1K | -2% | -$10.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-13 | F | D | 6,471 | $0.81 | 637,676 | D | — | — | (F1) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 383,500 unvested restricted stock. |
| 2 | Common | Common Stock | 2022-01-14 | F | D | 6,611 | $0.82 | 631,065 | D | — | — | (F1) Shares withheld as payment of a tax liability on vesting of restricted stock. (F3) Includes 371,750 unvested restricted stock. |